BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38481717)

  • 21. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.
    Griese DP; Reents W; Diegeler A; Kerber S; Babin-Ebell J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E734-41. PubMed ID: 23765732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide.
    Moriyama N; Lindström L; Laine M
    EuroIntervention; 2019 Feb; 14(15):e1558-e1565. PubMed ID: 30295293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound-Guided Versus Conventional MANTA Vascular Closure Device Deployment After Transcatheter Aortic Valve Implantation.
    Miyashita H; Moriyama N; Dahlbacka S; Vähäsilta T; Vainikka T; Jalanko M; Viikilä J; Laine M
    Am J Cardiol; 2022 Oct; 180():116-123. PubMed ID: 35933223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the MANTA device to rescue failed pre-closure following transfemoral transcatheter aortic valve implantation.
    Ali N; Blackman DJ; Cunnington M; Malkin CJ
    J Cardiol Cases; 2019 Mar; 19(3):81-84. PubMed ID: 30949246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide.
    Hoffmann P; Al-Ani A; von Lueder T; Hoffmann J; Majak P; Hagen O; Loose H; Kløw NE; Opdahl A
    CVIR Endovasc; 2018; 1(1):20. PubMed ID: 30652151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the MANTA closure device in transfemoral transcatheter aortic valve replacement: a single-centre observational study.
    Halim J; Missault L; Lycke M; Van der Heyden J
    Neth Heart J; 2020 Dec; 28(12):639-644. PubMed ID: 32720122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
    Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
    EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new Percutaneous technique for effective vascular Access Site closure in patients undergoing Transfemoral aortic valve implantation and thoraco-abdominal aortic aneurysm rEpair: the PASTE study.
    Sorropago G; Singh G; Sorropago A; Sole A; Rossi J; Tolva VS; Stabile E; Scalise F
    EuroIntervention; 2018 Dec; 14(12):e1278-e1285. PubMed ID: 30327287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Kroon HG; Tonino PAL; Savontaus M; Amoroso G; Laine M; Christiansen EH; Toggweiler S; Ten Berg J; Sathananthan J; Daemen J; de Jaegere PP; Brueren GBRG; Malmberg M; Slagboom T; Moriyama N; Terkelsen CJ; Moccetti F; Gheorghe L; Webb J; Wood D; Van Mieghem NM
    Catheter Cardiovasc Interv; 2021 May; 97(6):1270-1278. PubMed ID: 33347739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Totally Percutaneous Transfemoral Transcatheter Aortic Valve Replacement Despite Failure to Deploy a Vascular Closure Device: A Single-Centre Case Series.
    Eitan A; Shiran A; Sliman H; Zafrir B; Jaffe R
    Heart Lung Circ; 2022 Mar; 31(3):390-394. PubMed ID: 34607752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Barbash IM; Wasserstrum Y; Erlebach M; Guetta V; Ziegelmüller J; Segev A; Fefer P; Maor E; Lange R; Ruge H
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):160-168. PubMed ID: 38059295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular Complications in Transcatheter Aortic Valve Replacement With Plug-Based vs Suture-Based Closure Devices.
    Zornitzki L; Zahler D; Frydman S; Itach T; Ben-Shoshan J; Halkin A; Bazan S; Arbel Y; Konigstein M; Finkelstein A; Banai S; Steinvil A
    Can J Cardiol; 2023 Nov; 39(11):1528-1534. PubMed ID: 37419247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular complications after percutaneous mitral valve repair and venous access closure using suture or closure device.
    Steppich B; Stegmüller F; Rumpf PM; Pache J; Sonne C; Lesevic H; Braun D; Hausleiter J; Kasel AM; Ott I
    J Interv Cardiol; 2018 Apr; 31(2):223-229. PubMed ID: 29148095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large-bore arterial access closure after transcatheter aortic valve replacement: a systematic review and network meta-analysis.
    Montalto C; Munafò AR; Arzuffi L; Soriano F; Mangieri A; Nava S; De Maria GL; Burzotta F; D'Ascenzo F; Colombo A; Latib A; Oreglia JA; Banning AP; Porto I; Crimi G
    Eur Heart J Open; 2022 Jul; 2(4):oeac043. PubMed ID: 36117948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI.
    Kmiec L; Zerdzitzki M; Schmid C; Debl K; Sossalla S; Hilker M; Holzamer A
    Thorac Cardiovasc Surg; 2023 Mar; 71(2):84-93. PubMed ID: 34176110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
    El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
    EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Saleh N; De Palma R; Settergren M; Rück A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation.
    Biancari F; Romppanen H; Savontaus M; Siljander A; Mäkikallio T; Piira OP; Piuhola J; Vilkki V; Ylitalo A; Vasankari T; Airaksinen JKE; Niemelä M
    Int J Cardiol; 2018 Jul; 263():29-31. PubMed ID: 29681408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.